These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33752610)

  • 1. Using item response theory (IRT) to improve the efficiency of the Simple Clinical Colitis Activity Index (SCCAI) for patients with ulcerative colitis.
    Walsh A; Cao R; Wong D; Kantschuster R; Matini L; Wilson J; Kormilitzin A; South M; Travis S; Bauermeister S
    BMC Gastroenterol; 2021 Mar; 21(1):132. PubMed ID: 33752610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.
    Bennebroek Evertsz' F; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
    J Crohns Colitis; 2013 Dec; 7(11):890-900. PubMed ID: 23269224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
    J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Golovics PA; Gonczi L; Reinglas J; Verdon C; Pundir S; Afif W; Wild G; Bitton A; Bessissow T; Lakatos PL
    Dig Dis Sci; 2022 Jul; 67(7):3089-3095. PubMed ID: 34286411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Marín-Jiménez I; Nos P; Domènech E; Riestra S; Gisbert JP; Calvet X; Cortés X; Iglesias E; Huguet JM; Taxonera C; Fernández R; Carpio D; Gutiérrez A; Guardiola J; Laria LC; Sicilia B; Bujanda L; Cea-Calvo L; Romero C; Rincón Ó; Juliá B; Panés J
    Am J Gastroenterol; 2016 Feb; 111(2):261-8. PubMed ID: 26753886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.
    Theede K; Kiszka-Kanowitz M; Nielsen AM; Nordgaard-Lassen I
    Scand J Gastroenterol; 2014 Apr; 49(4):418-23. PubMed ID: 24495103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Perceived Stress is Associated With Increased Risk of Ulcerative Colitis Clinical Flares.
    Sauk JS; Ryu HJ; Labus JS; Khandadash A; Ahdoot AI; Lagishetty V; Katzka W; Wang H; Naliboff B; Jacobs JP; Mayer EA
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):741-749.e3. PubMed ID: 35952942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.
    Bewtra M; Brensinger CM; Tomov VT; Hoang TB; Sokach CE; Siegel CA; Lewis JD
    Inflamm Bowel Dis; 2014 Jun; 20(6):1070-8. PubMed ID: 24810138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the Escalation of Therapy or Intervention (ETI) Calculator for Patients with Ulcerative Colitis Using ePROMs.
    Matini L; Chapman TP; Kantschuster R; Wilson J; Tarafdar A; Hussain M; Song K; Simadibrata DM; Seeva P; White L; Slater J; Kormilitzin A; ; Collins G; Travis SPL; Walsh A
    J Crohns Colitis; 2023 Nov; 17(11):1744-1751. PubMed ID: 37306285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
    Panés J; Domènech E; Aguas Peris M; Nos P; Riestra S; Juliá de Páramo B; Cea-Calvo L; Romero C; Marín-Jiménez I
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1818-1824. PubMed ID: 28370253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.
    Castaneda G; Liu B; Torres S; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Oct; 62(10):2876-2881. PubMed ID: 28856475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC).
    Marcovitch L; Nissan A; Mack D; Otley A; Hussey S; Mclean B; Lewis M; Croft N; Barakat FM; Griffiths AM; Turner D
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):373-377. PubMed ID: 27159210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?
    Higgins PD; Schwartz M; Mapili J; Zimmermann EM
    Am J Gastroenterol; 2005 Feb; 100(2):355-61. PubMed ID: 15667493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.
    Long MD; Afzali A; Fischer M; Hudesman D; Abdalla M; McCabe R; Cohen BL; Ungaro RC; Harlan W; Hanson J; Konijeti G; Polyak S; Ritter T; Salzberg B; Seminerio J; English E; Zhang X; Sharma PP; Herfarth HH
    Inflamm Bowel Dis; 2023 Apr; 29(4):570-578. PubMed ID: 35700276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
    Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH;
    Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of faecal calprotectin in ulcerative colitis - single centre experience.
    Grgić D; Golubić K; Brinar M; Krznarić Ž
    Ann Med; 2022 Dec; 54(1):1570-1577. PubMed ID: 35635011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool.
    Ghosh S; Sensky T; Casellas F; Rioux LC; Ahmad T; Márquez JR; Vanasek T; Gubonina I; Sezgin O; Ardizzone S; Kligys K; Petersson J; Suzuki Y; Peyrin-Biroulet L
    J Crohns Colitis; 2020 Jul; 15(2):228-37. PubMed ID: 32722760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.